Synopsys Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Synopsys heeft een totaal eigen vermogen van $7.7B en een totale schuld van $15.6M, wat de schuld-eigenvermogensverhouding op 0.2% brengt. De totale activa en totale passiva bedragen respectievelijk $11.6B en $3.9B. De EBIT Synopsys is $1.5B waardoor de rentedekking -48.6 is. Het heeft contanten en kortetermijnbeleggingen van $2.0B.
Belangrijke informatie
0.2%
Verhouding schuld/eigen vermogen
US$15.60m
Schuld
| Rente dekkingsratio | -48.6x |
| Contant | US$1.99b |
| Aandelen | US$7.75b |
| Totaal verplichtingen | US$3.90b |
| Totaal activa | US$11.65b |
Recente financiële gezondheidsupdates
Is Synopsys (NASDAQ:SNPS) Using Too Much Debt?
Nov 04
Is Synopsys (NASDAQ:SNPS) A Risky Investment?
Jul 11Synopsys (NASDAQ:SNPS) Has A Rock Solid Balance Sheet
Apr 02We Think Synopsys (NASDAQ:SNPS) Can Manage Its Debt With Ease
Oct 12Is Synopsys (NASDAQ:SNPS) Using Too Much Debt?
Jul 03Recent updates
Should You Be Adding Synopsys (NASDAQ:SNPS) To Your Watchlist Today?
Nov 17Is Synopsys (NASDAQ:SNPS) Using Too Much Debt?
Nov 04At US$507, Is It Time To Put Synopsys, Inc. (NASDAQ:SNPS) On Your Watch List?
Oct 21Synopsys Stock: Double-Digit Annual Returns Likely
Oct 07Earnings Tell The Story For Synopsys, Inc. (NASDAQ:SNPS)
Sep 26Synopsys: Fantastic Company With One Shortcoming
Aug 24Is Synopsys, Inc. (NASDAQ:SNPS) Worth US$549 Based On Its Intrinsic Value?
Aug 18Here's Why Synopsys (NASDAQ:SNPS) Has Caught The Eye Of Investors
Jul 25Synopsys: Market Position Boosted With Ansys Acquisition
Jul 17Is Synopsys (NASDAQ:SNPS) A Risky Investment?
Jul 11Synopsys, Inc.'s (NASDAQ:SNPS) P/E Still Appears To Be Reasonable
Jun 14What Is Synopsys, Inc.'s (NASDAQ:SNPS) Share Price Doing?
May 27Synopsys: Reasons To Hold Despite Perceived Overvaluation
May 23Synopsys: Selling On The Cheap Ahead Of The Ansys Deal
May 17Is Now The Time To Put Synopsys (NASDAQ:SNPS) On Your Watchlist?
Apr 16Synopsys: Potential Further Upside For Compounding Machine
Apr 04Synopsys (NASDAQ:SNPS) Has A Rock Solid Balance Sheet
Apr 02Synopsys: A Quality Compounder With A Stretched Valuation
Mar 25Synopsys (NASDAQ:SNPS) Might Have The Makings Of A Multi-Bagger
Mar 20Synopsys Q1 Earnings Preview: Why The ANSYS Acquisition May Destroy Shareholder Value
Feb 21With Synopsys, Inc. (NASDAQ:SNPS) It Looks Like You'll Get What You Pay For
Jan 23What Is Synopsys, Inc.'s (NASDAQ:SNPS) Share Price Doing?
Jan 09Here's Why Synopsys (NASDAQ:SNPS) Has Caught The Eye Of Investors
Dec 28Charting the Course: Unlocking Potential in Tech
Dec 15
Charting the Course: Unlocking Potential in Tech
Dec 15Calculating The Intrinsic Value Of Synopsys, Inc. (NASDAQ:SNPS)
Dec 13There's Been No Shortage Of Growth Recently For Synopsys' (NASDAQ:SNPS) Returns On Capital
Oct 25We Think Synopsys (NASDAQ:SNPS) Can Manage Its Debt With Ease
Oct 12Is It Time To Consider Buying Synopsys, Inc. (NASDAQ:SNPS)?
Sep 29A Look At The Intrinsic Value Of Synopsys, Inc. (NASDAQ:SNPS)
Aug 16Is Synopsys (NASDAQ:SNPS) Using Too Much Debt?
Jul 03Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( $5.1B ) SNPS } overtreffen de korte termijn passiva ( $2.5B ).
Langlopende schulden: De kortetermijnactiva SNPS ( $5.1B ) overtreffen de langetermijnschulden ( $1.4B ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: SNPS heeft meer geld in kas dan de totale schuld.
Schuld verminderen: De schuld/eigen vermogen-ratio van SNPS is de afgelopen 5 jaar gedaald van 3.6% naar 0.2%.
Schuldendekking: De schuld van SNPS wordt goed gedekt door de operationele kasstroom ( 7502.2% ).
Rentedekking: SNPS verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.